BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 219217)

  • 1. Morphological and biochemical characterization of viral particles produced by the tsO45 mutant of vesicular stomatitis virus at restrictive temperature.
    Schnitzer TJ; Dickson C; Weiss RA
    J Virol; 1979 Jan; 29(1):185-95. PubMed ID: 219217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a mutation in the VSV G protein on the synthesis and maturation of nucleocapsids.
    Marnell LL; Wertz GW
    J Gen Virol; 1982 May; 60(Pt 1):165-9. PubMed ID: 6284864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system.
    Lefkowitz EJ; Pattnaik AK; Ball LA
    Virology; 1990 Oct; 178(2):373-83. PubMed ID: 2171187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective isolation of mutants of vesicular stomatitis virus defective in production of the viral glycoprotein.
    Lodish HF; Weiss RA
    J Virol; 1979 Apr; 30(1):177-89. PubMed ID: 225514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fusion-defective mutant of the vesicular stomatitis virus glycoprotein.
    Whitt MA; Zagouras P; Crise B; Rose JK
    J Virol; 1990 Oct; 64(10):4907-13. PubMed ID: 2168975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport pathway, maturation, and targetting of the vesicular stomatitis virus glycoprotein in skeletal muscle fibers.
    Rahkila P; Alakangas A; Väänänen K; Metsikkö K
    J Cell Sci; 1996 Jun; 109 ( Pt 6)():1585-96. PubMed ID: 8799845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and maturation of a vesicular stomatitis virus temperature-sensitive mutant and its central nervous system isolate.
    Hughes JV; Johnson TC; Rabinowitz SG; Dal Canto MC
    J Virol; 1979 Jan; 29(1):312-21. PubMed ID: 219225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstituted G protein-lipid vesicles from vesicular stomatitis virus and their inhibition of VSV infection.
    Miller DK; Feuer BI; Vanderoef R; Lenard J
    J Cell Biol; 1980 Feb; 84(2):421-9. PubMed ID: 6247354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature-sensitive mutants of vesicular stomatitis virus: synthesis of virus-specific proteins.
    Printz P; Wagner RR
    J Virol; 1971 May; 7(5):651-62. PubMed ID: 4104253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid acylation is not required for membrane fusion activity or glycoprotein assembly into VSV virions.
    Whitt MA; Rose JK
    Virology; 1991 Dec; 185(2):875-8. PubMed ID: 1660205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.
    Owens RJ; Rose JK
    J Virol; 1993 Jan; 67(1):360-5. PubMed ID: 8093220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
    Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of vesicular stomatitis virus particles: implications for virion assembly.
    Lodish HF; Porter M
    J Virol; 1980 Jan; 33(1):52-8. PubMed ID: 6245248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the oligosaccharide structure of the glycoprotein of vesicular stomatitis virus and a thermolabile mutant (tl-17).
    Robertson JS; Etchison JR; Summers DF
    J Gen Virol; 1982 Jan; 58 Pt 1():13-23. PubMed ID: 6292339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components.
    Bishop DH; Repik P; Obijeski JF; Moore NF; Wagner RR
    J Virol; 1975 Jul; 16(1):75-84. PubMed ID: 166210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninfectious vesicular stomatitis virus particles deficient in the viral nucleocapsid.
    Schnitzer TJ; Lodish HF
    J Virol; 1979 Feb; 29(2):443-7. PubMed ID: 219239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.
    Abe A; Chen ST; Miyanohara A; Friedmann T
    J Virol; 1998 Aug; 72(8):6356-61. PubMed ID: 9658075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
    Johnson JE; Schnell MJ; Buonocore L; Rose JK
    J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions.
    McSharry JJ; Compans RW; Choppin PW
    J Virol; 1971 Nov; 8(5):722-9. PubMed ID: 4108932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.